SIMEST, a company that together with SACE forms the CDP Group’s export and internationalisation hub, has invested €2.3 million for a 49% stake in Medicina Futura Dubai, the Emirates subsidiary of the Naples-based Medicina Futura Group, active for over 40 years in the healthcare sector.
The investment will finance the construction of a new hospital in Dubai – to which Medicina Futura’s existing operations will be transferred and expanded – and numerous medical centres throughout the territory of the United Arab Emirates. The goal is to export a virtuous “Made in Italy” healthcare management approach and within the next few years become the leading operator in the health services market in the Emirates, offering state-of-the-art outpatient and hospital services. With the entry of its new institutional partner, SIMEST, Medicina Futura is underscoring the soundness of an Italian example of excellence, of its development project and, above all, of all the professional skills that have contributed to making it a national and international leader.
The Medicina Futura Group was founded in 1973, with the establishment in Acerra of the first multidisciplinary diagnostic centre in the Campania region. It now has a turnover of about €40 million and employs 310 staff at its 15 operational sites in Dubai, Rome, Naples and the surrounding province. It mainly operates as an accredited service provider within the Italian national health system.
Contact details for the media:
Tel: +39 06 68635.777
SIMEST is part of the CDP Group, 76% owned by SACE, with leading Italian banks and trade associations among its other investors. SIMEST and SACE form the export and internationalisation hub of the CDP Group, which offers the entire range of financial instruments to support Italian companies interested in competing and expanding internationally. In particular, SIMEST supports companies throughout their entire international development process, providing soft loans for internationalisation, export credit support and equity investments